Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Targeted Rheumatoid Arthritis Treatment Does Not Improve Mental Health

Will Boggs MD  |  June 14, 2018

“Ideally, multi-disciplinary rheumatology services would include dedicated psychology or liaison psychiatry time, providing psychological therapies or support patients with adjusting to the diagnosis, treatment regimens, and other behavioral or lifestyle changes needed to help improve health outcomes,” she said.

“Integrating mental-health services into routine clinical care is important to reduce stigma related to mental-health problems (as mental and physical health would be seen as equally important) and to ensure patients receive psychological support that is relevant to their physical health needs and rheumatological diagnosis,” Dr. Matcham added.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“If this is not possible, simply asking patients about their mental health as part of routine follow-up and creating standardized mental-health care pathways that make use of primary-care or community mental-health services can go a long way to improve the management of mental health needs,” she said.

Reference

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE
  1. Matcham F, Galloway J, Hotopf M, et al. The impact of targeted Rheumatoid Arthritis pharmacological treatment on mental health: A systematic review and network meta-analysis. Arthritis & Rheumatology. 2018 Jun 6. [Epub ahead of print]

Page: 1 2 | Single Page
Share: 

Filed under:Rheumatoid Arthritis Tagged with:Anti-TNFanxiety disordersdepressive disordersDisease-modifying antirheumatic drugs (DMARDs)Mental HealthpharmacotherapyRheumatoid Arthritis (RA)

Related Articles
    Yupa Watchanakit / shutterstock.com

    Experts Discuss Rheumatologists’ Role in Treating Depression, Anxiety and Psychological Comorbidities in Their Patients

    December 17, 2017

    All rheumatologists have observed the impact of their patients’ mental health status on the long-term treatment of rheumatologic conditions. Depression, anxiety and even loneliness can lead to poor clinical outcomes and nonadherence to treatment, whether the patient is following medication regimens or participating in regular exercise. On the other hand, a patient’s resilience and positive…

    Gout, Glucose Metabolism and Obesity: A Case Review

    November 2, 2014

    New research explores association between hyperurecimia and gout with metabolic derangement

    Depression & Anxiety Linked to Poor Rheumatoid Arthritis Outcomes

    September 18, 2015

    NEW YORK (Reuters Health)—Rheumatoid arthritis patients with depression and anxiety symptoms may have worse outcomes and poorer response to prednisolone, a secondary analysis of the CARDERA trial has found. “The strength of association between depression/anxiety and disease activity outcomes and treatment response warrants routine screening,” the study’s lead author Faith Matcham at King’s College London…

    An Improved State of Mind?

    September 4, 2018

    Evidence suggesting common inflammatory pathways in RA and depression is increasing. However, this study found that improved physical health through pharmacologic treatment does not by itself improve mental health. …

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences